Werewolf Therapeutics, Inc. (HOWL) Social Stream



Werewolf Therapeutics, Inc. (HOWL): $6.39

0.05 (-0.78%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add HOWL to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#49 of 359

in industry

WEREWOLF THERAPEUTICS INC (HOWL) Price Targets From Analysts

Use the tables below to see what analysts covering WEREWOLF THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 5 $32 $22 $26.4 $5.36 392.54%
2022-03-25 5 $32 $22 $26.2 $5.36 388.81%
2022-04-07 5 $32 $9 $22.8 $5.36 325.37%
2022-05-11 4 $23 $9 $18 $5.36 235.82%
2022-05-19 4 $22 $9 $16 $5.36 198.51%
2022-08-11 4 $22 $9 $17 $5.36 217.16%
2022-09-17 4 $20 $9 $16.5 $5.36 207.84%
2022-10-14 4 $20 $9 $16.75 $5.36 212.5%
2022-11-11 4 $20 $8 $16.5 $5.36 207.84%
2023-01-26 5 $20 $8 $14.86 $5.36 177.24%
2023-03-23 5 $20 $8.3 $15.06 $5.36 180.97%
2023-03-24 5 $20 $8.3 $13.26 $5.36 147.39%
2023-03-31 5 $20 $8.3 $12.66 $5.36 136.19%
2023-05-11 5 $15 $8.3 $11.66 $5.36 117.54%
2023-06-06 5 $15 $8.3 $11.86 $5.36 121.27%
2023-08-11 5 $15 $8.3 $12.06 $5.36 125%
2023-11-03 6 $15 $8.3 $11.55 $5.36 115.49%
2023-11-15 6 $15 $8.3 $12.05 $5.36 124.81%

The Trend in the Analyst Price Target


Over the past 15 months, HOWL's average price target has gone down $4.2.

Over the past 42 weeks, HOWL's average upside potential has been 366.07%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-31 5 20 8.3 12.66 2.60 386.92%
2023-05-11 5 15 8.3 11.86 2.77 328.16%
2023-06-06 5 15 8.3 11.86 3.47 241.79%
2023-08-24 6 15 8.3 11.55 3.27 253.21%
2023-11-03 6 15 8.3 11.55 3.17 264.35%

HOWL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 6 0 0 0 0 6

The Trend in the Broker Recommendations


Over the past 19 months, HOWL's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HOWL as an investment opportunity.

  • In the context of all US stocks, WEREWOLF THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1991.51% of them.
  • In terms of how WEREWOLF THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 413.12% of that group.
  • WEREWOLF THERAPEUTICS INC's average analyst price target is higher than 454.87% of all US stocks.
  • WEREWOLF THERAPEUTICS INC's variance in analysts' estimates is lower than -1510.56% of stocks in the small market cap category.

In the Pharmaceutical Products industry, JANX, IMRX, and RANI are the three stocks most similar to WEREWOLF THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Is HOWL a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!